Abstract
Adenine and uridine nucleotides evoke Ca2+ signals via four subtypes of P2Y receptor in cultured aortic smooth muscle cells, but the mechanisms underlying the different patterns of these Ca2+ signals are unresolved. Cytosolic Ca2+ signals were recorded from single cells and populations of cultured rat aortic smooth muscle cells, loaded with a fluorescent Ca2+ indicator and stimulated with agonists that allow subtype-selective activation of P2Y1, P2Y2, P2Y4, or P2Y6 receptors. Activation of P2Y1, P2Y2, and P2Y6 receptors caused homologous desensitisation, while activation of P2Y2 receptors also caused heterologous desensitisation of the other subtypes. The Ca2+ signals evoked by each P2Y receptor subtype required activation of phospholipase C and release of Ca2+ from intracellular stores via inositol 1,4,5-trisphosphate (IP3) receptors, but they were unaffected by inhibition of ryanodine or nicotinic acid adenine dinucleotide phosphate (NAADP) receptors. Sustained Ca2+ signals were independent of the Na+/Ca2+ exchanger and were probably mediated by store-operated Ca2+ entry. Analyses of single cells established that most cells express P2Y2 receptors and at least two other P2Y receptor subtypes. We conclude that four P2Y receptor subtypes evoke Ca2+ signals in cultured aortic smooth muscle cells using the same intracellular (IP3 receptors) and Ca2+ entry pathways (store-operated Ca2+ entry). Different rates of homologous desensitisation and different levels of receptor expression account for the different patterns of Ca2+ signal evoked by each P2Y receptor subtype.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The primary function of vascular smooth muscle cells (VSMC) is to contract and thereby to regulate vascular tone and blood pressure [1]. However, in response to local environmental cues such as interactions with other cells, the extracellular matrix or growth factors, and particularly during vascular injury, VSMC can change phenotype. They then lose their ability to contract and become able to proliferate. This switch from a contractile to a proliferative phenotype may be necessary for vascular repair, but it also plays a role in the development and progression of such vascular diseases as atherosclerosis, restenosis, and hypertension [2]. In culture, VSMC undergo similar phenotypic changes, losing some proteins that are typical of the contractile state, like L-type Ca2+ channels and ryanodine receptors (RyR) [1, 3]. Other proteins that are up-regulated in VSMC in vivo after vascular injury, like TRPC (transient receptor potential canonical) channels and the STIM1 proteins that regulate store-operated Ca2+ entry (SOCE), are also expressed at increased levels in cultured VSMC [1, 4]. Cultured VSMC are, therefore, a useful model of VSMC in diseased states [5, 6].
P2Y receptors are a family of G protein-coupled receptors that are activated by adenine and uridine nucleotides [7]. In VSMC, many functional responses are regulated by the Ca2+ signals evoked by purinoceptors [8, 9]. Analysis of these responses in native tissues is, however, made complicated by the diversity of P2Y receptors and the paucity of ligands with adequate selectivity for P2Y receptor subtypes. We recently established, using a combination of subtype-selective ligands and quantification of receptor expression, that four different P2Y receptor subtypes (P2Y1, P2Y2, P2Y4, and P2Y6) evoke Ca2+ signals in cultured rat aortic smooth muscle cells (ASMC) [10]. Two of these receptors (P2Y2 and P2Y4) probably respond to the same endogenous agonists (ATP and UTP), while the others respond to ADP (P2Y1) and UDP (P2Y6) [7]. Because all four P2Y receptors evoke Ca2+ signals and they are stimulated by interrelated agonists, it is worth considering why ASMC should express such a diversity of purinoceptors linked to Ca2+ signalling. The present study addresses this issue by characterizing the increases in cytosolic-free Ca2+ concentration ([Ca2+] i ) evoked by each P2Y receptor subtype in cultured ASMC, the roles of plasma membrane and intracellular Ca2+ channels in generating these Ca2+ signals, and the contribution of desensitisation to the very different Ca2+ signals evoked by each receptor subtype.
Materials and methods
Materials
Cell culture materials were from Gibco (Paisley, UK), except for foetal bovine serum (Sigma, Poole, UK). Fluo-4 AM and fura-2 AM were from Invitrogen (Paisley, UK). MRS2365 ((N)-methanocarba-2-methylthio-adenosine-5'-diphosphate), UDP, U73122 (1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione), U73343 (1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidinedione) and KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea) were from Tocris (Bristol, UK). 2'-amino-UTP (2'-amino-2'-deoxyuridine-5'-triphosphate) and 2'-azido-UTP (2'-azido-2'-deoxyuridine-5'-triphosphate) were from Trilink Biotechnologies (San Diego, CA). Ryanodine was from Ascent Scientific (Avonmouth, UK). Thapsigargin was from Alomone Labs (Jerusalem, Israel). Collagenase B and hexokinase were from Roche Diagnostics Ltd. (Burgess Hill, UK). Trans-Ned-19 (1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid) was from Enzo Life Sciences (Exeter, UK). All other reagents, including 2-aminoethoxydiphenyl borate (2-APB), cyclopiazonic acid (CPA), nimodipine, elastase, GdCl3 and probenecid, were from Sigma. Stocks of UDP (10 mM) were treated (1 h, 37 °C) with hexokinase (50 U mL-1, pH 7.0 in 0.1 M phosphate buffer containing 6.5 mM MgCl2 and 110 mM glucose) to remove contaminating UTP before use [10].
Isolation and culture of rat aortic smooth muscle cells
Methods to isolate and culture rat ASMC were described previously [10]. All animal care and experimental procedures complied with UK Home Office policy. Briefly, adult male rats were humanely killed by cervical dislocation. The aorta was isolated under sterile conditions in Hank's balanced salt solution (HBSS) supplemented with penicillin (100 U mL−1) and streptomycin (100 μg mL−1), and cleared of adhering fat, connective tissue and the inner endothelial layer. After digestion (37 °C, 12 min) in HBSS containing antibiotics and collagenase B (0.015 U mL−1), the adventitia were removed, and the tissue was further digested (37 °C, 90 min) in HBSS containing antibiotics, collagenase B (0.075 U mL−1) and elastase (8 U mL−1). Single cells were then dispersed by trituration with a sterile Pasteur pipette. The cells were washed with Dulbecco's modified Eagle's medium (DMEM) (650 g, 5 min), resuspended in DMEM with antibiotics and foetal calf serum (10 %) and grown at 37 °C in a humidified atmosphere of 95 % air and 5 % CO2. ASMC were either passaged or frozen when they reached confluence.
Measurement of [Ca2+] i in cell populations
Confluent cultures of ASMC grown in 96-well plates were loaded with fluo-4 by incubation with fluo-4 acetoxymethyl ester (fluo-4 AM, 4 μM in fresh dimethyl sulfoxide (DMSO); final DMSO concentration, 0.4 %) in HEPES-buffered saline (HBS) supplemented with probenecid (2.5 mM). After 1 h at 20 °C, cells were washed with HBS, and after a further 15 min, they were used for experiments. HBS had the following composition: 135 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 11.5 mM glucose, 11.6 mM HEPES, pH 7.3, at 20 °C. All experiments were performed in HBS (or nominally Ca2+-free HBS) at 20 °C. We confirmed that incubating cells in nominally Ca2+-free HBS was as effective as incubation in Ca2+-free HBS with 1 mM EGTA in preventing both Ca2+ entry evoked by activation of P2Y2 receptors and refilling of intracellular stores with Ca2+ (Online Resource, Supplementary Fig. S1). Fluorescence (excitation at 485 nm, emission at 525 nm) was recorded from the 96-well plate using a FlexStation III (MDS Analytical Technologies Wokingham, Berks, UK) [10]. At the end of each experiment, fluorescence of Ca2+-saturated indicator (F max) was determined for each well by addition of Triton X-100 (0.05 %) and CaCl2 (10 mM). Background fluorescence, measured in parallel from cells treated with Triton X-100 (0.05 %) and BAPTA (10 mM), was subtracted from all measurements. The corrected fluorescence (F) was then calibrated to [Ca2+] i : [Ca2+] i = K D.F/(F max − F), where the K D of fluo-4 for Ca2+ is 345 nM [10].
Because it is difficult to wash ASMC in 96-well plates without causing some detachment of cells (usually <10 %), comparisons between treatments that required changes of media were always performed using controls matched to ensure identical washing procedures.
Single-cell measurement of [Ca2+] i
ASMC grown to ~75 % confluence on 22-mm round glass coverslips coated with poly-l-lysine (0.01 %) were loaded with fura-2 exactly as described for fluo-4. Fluorescence from single cells at 20 °C was recorded (emission >510 nm) using an Olympus IX71 inverted fluorescence microscope and Luca EMCCD camera (Andor Technology, Belfast, UK) at 5-s intervals with alternating excitation at 340 and 380 nm. All recordings were corrected for autofluorescence determined at the end of each experiment by addition of MnCl2 (10 mM) and ionomycin (1 μM). The corrected fluorescence readings (F 340 and F 380) were calibrated to [Ca2+] i from: \( {\left[ {C{a^{{2 + }}}} \right]_i} = {K_D}\frac{{\left( {R - {R_f}} \right){F_{\text{f}}}}}{{\left( {{R_{\text{b}}} - R} \right){F_{\text{b}}}}} \) where K D is the equilibrium dissociation constant of fura 2 for Ca2+ (220 nM), R is the fluorescence ratio (F 340/F 380) from the cells. R f and R b were determined in vitro using Ca2+ calibration buffer kit#1 (Invitrogen) in Ca2+-free and Ca2+-saturating conditions, respectively; and F f and F b are the fluorescence intensities determined after excitation at 380 nm for Ca2+-free and Ca2+-saturated indicator, respectively [11].
Data analysis
Concentration–effect relationships were fitted to Hill equations (GraphPad Prism, version 5, La Jolla, CA) to allow estimation of the maximal effects, Hill coefficients and −logEC50 (pEC50) (or pIC50) values. Results are presented as means ± SEM from n independent experiments (n = 3, unless otherwise stated). Statistical comparisons used one-tailed paired or unpaired Student's t test, as appropriate, with P < 0.05 considered significant.
Results
Ca2+ signals evoked by P2Y receptor subtypes
We used the conditions established in our previous work to stimulate selectively the four P2Y receptor subtypes expressed in cultured rat ASMC that evoke Ca2+ signals [10]. That study and previous work had shown that cultured ASMC do not express functional P2X receptors [10, 12]. MRS2365 was used selectively to activate P2Y1 receptors [13], 2'-amino-UTP for P2Y2 receptors, 2'-azido-UTP for P2Y4 receptors [14] and UDP for P2Y6 receptors [15]. For simplicity, we refer in the text only to the subtype of P2Y receptor that the agonist selectively activates, rather than to the agonists themselves. Details of the stimuli used are defined in the figure legends.
Within a single experiment using populations of ASMC, the amplitude of the peak Ca2+ signal evoked by activation of each P2Y receptor was similar between replicates, but there was greater variability between experiments, which included cells from both different animals and cell passages (Fig. 1a). We have not explored this variability further, although differences in the expression levels of P2Y receptors and/or the proteins that link them to Ca2+ signals are likely causes. Despite this variability in the amplitudes of the Ca2+ signals, there are clear and consistent differences in the relative amplitudes and time courses of the Ca2+ signals evoked by the four P2Y receptor subtypes. P2Y2 receptors invariably evoked the largest Ca2+ signals, and P2Y2, P2Y4, P2Y6, though not P2Y1, receptors evoked responses that were sustained by Ca2+ entry (Fig. 1, a–e). The Ca2+ signals evoked by activation of each of the four P2Y receptor subtypes were abolished by U73122 (20 μM), an inhibitor of phospholipase C (PLC), but unaffected by its inactive analogue, U73343 (20 μM) (Fig. 1f). These results establish that each of the four P2Y receptor subtypes (P2Y1, P2Y2, P2Y4, and P2Y6) evoke Ca2+ signals via activation of PLC, but the patterns of response are subtype-selective. Subsequent experiments examine the mechanisms responsible for the different Ca2+ signals evoked by each P2Y receptor subtype.
Homologous desensitisation of P2Y receptor signalling
Figure 2a shows the protocol used to determine whether stimulation of each P2Y receptor subtype affected the Ca2+ signal evoked by subsequent stimulation of the same receptor. This comprised an initial 60-s period of stimulation, after which the agonist was removed by washing and then restored after an interval of between 5 and 60 min. Because washing invariably caused some loss of cells (making it difficult to compare responses to sequential stimuli directly, see “Materials and methods” section), we measured desensitisation by comparing responses to the second stimulus after an initial incubation with or without the first stimulus. The results are shown in Fig. 2b, c.
Within the minimal period of 5 min required to wash the cells and re-apply the stimulus, the response to P2Y4 receptors had fully recovered, suggesting either that there was no desensitisation or that it fully reversed within 5 min (Fig. 2b, c). Responses from P2Y1, P2Y2, and P2Y6 receptors were reduced by prior stimulation of the same receptor. The desensitisation detected after a 5-min period of recovery was greatest for P2Y1 (72 ± 3 %), but significant (P < 0.05) also for P2Y2 (21 ± 7 %) and P2Y6 (30 ± 10 %) receptors. P2Y6 receptors recovered fully within 10 min. The lesser desensitisation of P2Y2 receptors recovered rather slowly, being almost complete (to 90 ± 2 % of control) within 60 min. Recovery of P2Y1 receptors was very slow and still incomplete after 60 min (to 66 ± 11 % of control) (Fig. 2b, c). Others have suggested, from analyses of inositol phosphate accumulation in response to activation of heterologously expressed human receptors, that P2Y6 receptors desensitise only very slowly (hours, rather than minutes), while activation of P2Y4 receptors causes their rapid desensitisation and internalisation [16, 17]. The latter differs from our observations, where P2Y4 receptors evoked prolonged Ca2+ signals (Figs. 1a, d and 8c) with no evidence of sustained desensitisation (Table 1). Different levels of expression of P2Y4 receptors in native cells and after heterologous expression or species differences [18] may contribute to the different patterns of desensitisation. The behaviours of P2Y6 receptors in ASMC and after heterologous expression [16, 17] are more easily reconciled. In ASMC, P2Y6 receptors evoked sustained Ca2+ signals (Figs. 1a, e and 8d) and our evidence suggests a modest, but rapidly reversed (Fig. 2b, c; Table 1), homologous desensitisation. The rapid onset and reversal of this desensitisation is likely to cause a modest acute ‘steady-state’ desensitisation of P2Y6 receptors that would be difficult to resolve with assays of inositol phosphate accumulation. The time courses of the experiments we describe would not have detected the much slower and more complete desensitisation of P2Y6 receptors that others have observed [16, 17].
Slow recovery of the ability of P2Y1 receptors to evoke Ca2+ signals might result from either slow refilling of intracellular stores after the first response and/or sustained attenuation of the coupling between extracellular stimuli and activation of signalling pathways. Two lines of evidence establish that the rate at which stores refill with Ca2+ is more rapid than recovery of the responses to P2Y1 receptors. First, P2Y2 receptors are expressed in almost all cells (the evidence is presented later) and they trigger the largest Ca2+ responses (Fig. 1a, f). Their ability to evoke Ca2+ signals that were only minimally reduced by prior stimulation (Fig. 2b, c) argues that slow refilling of stores is an unlikely explanation for the reduced responses observed for other P2Y receptor subtypes. Additional evidence is provided by examining the recovery of responses to P2Y2 receptors after restoration of extracellular Ca2+ to cells in which the Ca2+ stores had been emptied by reversible inhibition of the endoplasmic reticulum Ca2+ pump (SR/ER Ca2+-ATPase, SERCA) using cyclopiazonic acid (CPA, 10 μM, 35 min in Ca2+-free HBS). After a 2-min period of store refilling, the peak Ca2+ signal evoked by activation of P2Y2 receptors had recovered by 72 ± 6 % and to 81 ± 4 % after 5 min (data not shown). We conclude that the substantial homologous desensitisation observed for P2Y1 and P2Y6 receptors is not due to slow refilling of intracellular Ca2+ stores.
Heterologous desensitisation of P2Y receptor signalling
Using the same protocol applied to examine homologous desensitisation in cell populations, we assessed the effects of first stimulating one P2Y receptor subtype and then another (Fig. 3a). The P2Y2 receptor was the only subtype to cause significant attenuation of the global Ca2+ signals evoked by subsequent activation of a different subtype in populations of ASMC (Fig. 3b and Table 1). Indeed stimulation of P2Y2 receptors caused a greater reduction in the responses evoked by the other three subtypes (~40–50 %) than it caused to the response evoked by a second stimulation of P2Y2 receptors (23 ± 4 %) (Table 1).
Distribution of P2Y receptor subtypes between aortic smooth muscle cells
Analyses of homologous desensitisation in cell populations are straightforward because the sequential stimuli are likely to stimulate the same cells (Fig. 2). But for analyses of heterologous agonists, there is an additional complexity because individual cells may differ in the stimuli to which they respond. The apparent lack of heterologous desensitisation among P2Y1, P2Y4 and P2Y6 receptors (Table 1) might then simply reflect the presence of each receptor subtype in a different population of cells. Immunocytochemistry using subtype-selective P2Y receptor antibodies [19] or single-cell analysis of mRNA might reveal whether cells co-express different P2Y receptor subtypes, but it would be impracticable to examine all four subtypes simultaneously and nor could it prove that the receptors are functional. We, therefore, used the following two methods to assess whether different functional P2Y receptor subtypes co-exist in the same cell.
In the first approach, we sequentially stimulated populations of cells with two stimuli in Ca2+-free medium, arguing that depletion of a finite Ca2+ store by one stimulus should diminish the response to a second stimulus if they share the same intracellular Ca2+ stores. The results to these experiments reveal two important features (Fig. 4a and Table 2). As expected, the response to a second challenge with each homologous agonist was generally reduced, but it was not abolished (Table 2). This suggests either that even relatively sustained maximal stimulation fails to empty entirely the intracellular Ca2+ stores to which each receptor subtype has access, or that the relevant stores can partially refill after agonist removal despite the absence of extracellular Ca2+. The second point is that prior stimulation of P2Y2 receptors substantially attenuates responses to all other P2Y receptor subtypes, suggesting that cells expressing P2Y1, P2Y4 or P2Y6 receptors usually co-express P2Y2 receptors. Responses to P2Y1 receptors were attenuated by prior stimulation of each of the other P2Y receptor subtypes, suggesting that many cells that express P2Y1 receptors co-express at least one other P2Y receptor subtype.
A second approach used single-cell Ca2+ imaging to examine the responses of individual cells to activation of each of the four P2Y receptor subtypes. Almost all cells (95 ± 2 %, n = 92 cells from 5 coverslips) responded to activation of P2Y2 receptors with an increase in [Ca2+] i . This is consistent with their ability both to evoke the largest Ca2+ signals in cell populations (Fig. 1) and to deplete the Ca2+ stores to which other P2Y receptors have access (Table 2). We therefore restricted our subsequent single-cell analyses of sequential stimuli to P2Y1, P2Y4 and P2Y6 receptors. Cells in normal HBS were stimulated briefly (60 s) with a maximally effective concentration of a subtype-selective agonist, washed and after a 5-min period of recovery, stimulated with the second agonist, and then, after a further wash and recovery, stimulated with the third agonist (Fig. 4b). From these results, where we varied the sequence in which the agonists were presented to avoid bias, we established the distribution of responsiveness among 158 cells. The results show that 33 %, 43 % and 70 % of cells responded to activation of P2Y1, P2Y4 and P2Y6 receptors, respectively (Fig. 4c), and from the preceding analysis, 95 ± 2 % of cells responded to activation of P2Y2 receptors. These single-cell analyses of P2Y receptor distribution are consistent with the observation that P2Y2 receptors cause heterologous desensitisation of the other subtypes (Table 1) and depletion of the Ca2+ stores from which each of the other P2Y receptor subtypes evokes Ca2+ release (Table 2). Furthermore, the ability of P2Y4 and P2Y6 receptors to cause ~50 % loss of Ca2+ from the stores released by P2Y1 receptors is consistent with the overlapping expression of these three receptor subtypes (Fig. 4c and Table 2). The substantially overlapping expression of P2Y receptor subtypes in individual ASMC (Fig. 4c) suggests also that the lack of heterologous desensitisation among P2Y1, P2Y4 and P2Y6 receptors is not due to their expression in distinct populations of cells.
All P2Y receptors stimulate Ca2+ release via inositol 1,4,5-trisphosphate (IP3) receptors
Evidence that each P2Y receptor subtype evokes Ca2+ signals in the absence of extracellular Ca2+ (Fig. 1b–e) [10] and that each requires PLC activity (Fig. 1f) suggests that IP3 and IP3 receptors (IP3R) are likely to be essential components of the signalling pathway recruited by each P2Y receptor subtype. But the universal requirement for IP3 need not exclude the involvement of additional intracellular Ca2+ channels, or the possibility that any such involvement might be specific to particular P2Y receptor subtypes. The most likely candidates are RyR and two pore channels (TPC), which are activated by nicotinic acid adenine dinucleotide phosphate (NAADP). Each of these channels is expressed in many cell types including VSMC [20, 21].
Caffeine stimulates RyR [22], but at concentrations (1–10 mM) known to activate RyR maximally, caffeine had no effect on [Ca2+] i in cultured ASMC (Fig. 5a). Furthermore, ryanodine under conditions that block the activity of RyR (100 μM, pretreatment for 30 min) [23] had no effect on either the peak (Fig. 5b) or sustained Ca2+ signals (data not shown) evoked by activation of any of the P2Y receptor subtypes. These results are consistent with previous reports showing that expression of RyR in VSMC is repressed in cells with a proliferative phenotype [3].
Trans Ned-19 is an antagonist of NAADP-evoked Ca2+ signals. It interacts with TPC, although its mode of action is incompletely defined [24]. A concentration of trans Ned-19 (100 nM) that effectively blocks NAADP-evoked responses in many other cells had no effect on the Ca2+ signals evoked by maximal concentrations of the subtype-selective agonists of P2Y receptors (Fig. 5c). The effectiveness of trans Ned-19 was confirmed in parallel analyses of SKBR3 cells where the same concentration (100 nM) inhibited Ca2+ signals evoked by micro-injected NAADP [25]. This suggests that NAADP plays no significant part in the Ca2+ signals evoked by stimulation of any P2Y receptors in cultured ASMC.
There are no selective membrane-permeant antagonists of IP3R [26]. 2-aminoethoxydiphenylborane (2-APB) inhibits IP3R, but at higher concentrations, it inhibits SERCA [27] and enhances a non-specific leak of Ca2+ from intracellular stores [28]. 2-APB also has complex effects on store-operated Ca2+ entry (SOCE, discussed below) and other Ca2+ entry pathways [27, 29]. The peak Ca2+ signals evoked by maximal activation of P2Y1, P2Y4 and P2Y6 receptors were almost abolished by 2-APB (300 μM, pre-treated for 3 min) (Fig. 5d), whereas for P2Y2 receptors, the response was substantially attenuated (by 61 ± 10 %), but abolished only after submaximal stimulation (Fig. 5d). Although the actions of 2-APB at IP3R are ill-defined, it does not compete with IP3 for its binding site [27] and it more effectively inhibits submaximally stimulated IP3R [30]. The latter observation probably explains the greater effectiveness of 2-APB against those P2Y receptors that evoke the smallest Ca2+ signals (P2Y1, P2Y4 and P2Y6, Fig. 1a) and against submaximally, rather than maximally, activated P2Y2 receptors (Fig. 5d).
Caffeine is a low-affinity antagonist of IP3R [22], though it too has many additional actions. A high concentration of caffeine (100 mM, pretreated for 1 min) substantially inhibited the Ca2+ signals evoked by each of the four P2Y receptor subtypes (by ~75 %, not shown), but at this concentration, it is impossible to conclude that this results from a specific interaction of caffeine with IP3R. A lower concentration of caffeine (10 mM, pre-treated for 3 min), caused lesser (at least 22 %), but significant (P < 0.05), inhibition of the Ca2+ release evoked by each of the four P2Y receptor subtypes (Fig. 5e). Xestospongin C is another poorly characterised antagonist of IP3R [22]. We have not succeeded in achieving substantial and selective inhibition of IP3R in other cell types using xestospongin C and nor, in limited experiments (constrained by the cost of xestospongin C), did xestospongin C (10 μM) inhibit Ca2+ signals evoked by P2Y receptors in ASMC (data not shown).
The Ca2+ release evoked by all four P2Y receptors requires activation of PLC (Fig. 1f) and it is independent of both RyR (Fig. 5b) and TPC (Fig. 5c). This evidence, together with that provided by two, albeit imperfect, antagonists of IP3R (2-APB and caffeine) (Fig. 5d, e) strongly suggest that IP3R are entirely responsible for the Ca2+ release evoked by each P2Y receptor subtype in cultured ASMC.
Mechanisms of Ca2+ entry
In the absence of extracellular Ca2+, the Ca2+ signals evoked by activation of each of the P2Y receptor subtypes were transient and complete within about 5 min (Fig. 1b–e) [10]. This indicates that any sustained responses require Ca2+ entry across the plasma membrane. Figure 1a shows that P2Y2, P2Y4 and P2Y6 receptors stimulate Ca2+ entry, while there is no detectable sustained response to activation of P2Y1 receptors. The latter probably results from the rapid homologous desensitisation of P2Y1 receptors (Fig. 2b, c). Subsequent experiments examine the mechanisms responsible for the Ca2+ entry evoked by P2Y2, P2Y4 and P2Y6 receptors.
Depolarisation of the plasma membrane by addition of HBS containing 53 mM KCl in place of NaCl had no effect on [Ca2+] i in ASMC (data not shown). Nimodipine (100 nM), an inhibitor of L-type Ca2+ channels, had no effect on either the peak or sustained Ca2+ signals evoked by activation of any of the P2Y receptor subtypes (Fig. 6a). In parallel experiments with A7r5 cells, KCl did evoke an increase in [Ca2+] i that was blocked by nimodipine, confirming the effectiveness of the treatments in cells that do express functional L-type Ca2+ channels. These results, suggesting that L-type Ca2+ channels do not contribute to the Ca2+ signals evoked by P2Y receptors in ASMC, are consistent with evidence that L-type Ca2+ channels are down-regulated in the proliferative phenotype of VSMC [1].
Ca2+ can also enter cells across the plasma membrane in exchange for Na+ extrusion via the Na+/Ca2+ exchange (NCX) operating in ‘reverse mode’. It has been suggested that ATP-evoked Ca2+ entry in cultured ASMC is entirely mediated by the NCX working in reverse mode [31]. The diacylglycerol produced by PLC is proposed to open a non-selective cation channel formed by transient receptor potential canonical 6 (TRPC6) proteins allowing Na+ entry. The local increase in cytosolic Na+ concentration is then suggested to allow the NCX to operate in reverse mode, and so mediate Ca2+ entry [31, 32]. KB-R7943, at a concentration (10 μM) known to be selective for inhibition of NCX working in reverse mode [33], had no effect on either the peak (data not shown) or sustained Ca2+ signals evoked by activation of any of the P2Y receptor subtypes (Fig. 6b). Furthermore, complete replacement of extracellular Na+ (NaCl replaced by N-methyl-d-glucamine in HBS) had no effect on the Ca2+ signals evoked by P2Y receptors (Fig. 6c). These results establish that in our preparations of cultured rat ASMC, the NCX operating in reverse mode does not contribute to Ca2+ entry. We cannot easily explain the disparity with work from van Breemen and colleagues [31, 32], although we note that they used rat ASMC from rather later passages (passages 8–12) than ours (passages 2–8).
Treatment of cultured ASMC with thapsigargin (an inhibitor of SERCA) in Ca2+-free HBS (1 μM, 30 min) emptied intracellular Ca2+ stores. Restoring extracellular Ca2+ then evoked a modest increase in [Ca2+] i (152 ± 7 nM), whereas in cells treated similarly, but without thapsigargin, the increase was very small (18 ± 2 nM) (Fig. 6d). These results, which confirm the presence of SOCE in ASMC, are consistent with many studies [4, 34]. SOCE is typically sensitive to block by low concentrations of Gd3+ [35, 36]. GdCl3 caused a concentration-dependent inhibition of the thapsigargin-evoked SOCE in ASMC (pIC50 = 6.13 ± 0.1) (Fig. 6e). GdCl3 also caused a concentration-dependent inhibition of the Ca2+ entry evoked by P2Y2, P2Y4 and P2Y6 receptors, and for each the sensitivity (pIC50 ~6) was similar to that for inhibition of thapsigargin-evoked SOCE (Table 3). Whereas the maximal inhibition by Gd3+ was similar for thapsigargin-evoked SOCE and Ca2+ entry evoked by P2Y2 receptors, the lesser Ca2+ entry evoked by P2Y4 and P2Y6 receptors was less completely inhibited (Table 3). It is unclear whether this reflects a small SOCE-independent component of Ca2+ entry or the experimental difficulty of quantitatively analysing inhibition of the very small Ca2+ entry signals evoked by P2Y4 and P2Y6 receptors (Fig. 1). The peak increases in [Ca2+] i , which are almost entirely due to release of Ca2+ from intracellular stores [10], were unaffected by Gd3+ (data not shown).
SOCE is also sensitive to inhibition by low concentrations of 2-APB [29, 37]. 2-APB independently inhibits IP3R and SOCE, and its effects on the latter are often biphasic, causing stimulation at low concentrations (<5 μM) and inhibition at higher concentrations (>10 μM) [37, 38]. 2-APB caused a concentration-dependent inhibition of thapsigargin-evoked SOCE (pIC50 = 5.83 ± 0.04), but the inhibition, although clearly maximal, was incomplete (57 ± 12 % inhibition at 100 μM) (Fig. 6f and Table 4). Inhibition of SOCE by relatively low concentrations of 2-APB, with no evidence of it causing stimulation, is consistent with another study of ASMC [34]. The effects of 2-APB on Ca2+ entry evoked by P2Y receptors are more difficult to interpret because 2-APB also inhibits the IP3R, which we have shown to be necessary for all P2Y receptors to empty intracellular Ca2+ stores and thereby activate SOCE. For each P2Y receptor, the sensitivity to inhibition (pIC50 ~6) and the maximal effect of 2-APB on Ca2+ entry were similar to its effects on thapsigargin-evoked Ca2+ entry (Table 4 and Fig. 7). Furthermore, the peak Ca2+ signals evoked by P2Y receptors were less sensitive than Ca2+ entry to inhibition by 2-APB, although the difference was statistically significant for only P2Y2 receptors (Table 4). These results are consistent with each receptor evoking Ca2+ entry primarily via SOCE. The evidence is most compelling for P2Y2 receptors, where maximal inhibition of Ca2+ entry by 2-APB occurred with no detectable inhibition of Ca2+ release from intracellular stores (Table 4). Our results with low concentrations of Gd3+ and 2-APB suggest, although not conclusively, that SOCE mediates the Ca2+ entry evoked by P2Y2 receptors, and perhaps also by P2Y4 and P2Y6 receptors. Similar results have been reported for the Ca2+ entry evoked by platelet-derived growth factor (PDGF) in cultured rat ASMC [39].
Discussion
Four subtypes of P2Y receptor evoke Ca2+ signals in cultured ASMC [10] and while each requires activation of PLC (Fig. 1f), the responses differ considerably in their amplitudes, durations and requirement for Ca2+ entry across the plasma membrane (Fig. 1). In populations of cultured ASMC, P2Y2 receptors evoke the largest Ca2+ signals (Fig. 1). This results from both expression of functional P2Y2 receptors in most cells and their ability to evoke the largest Ca2+ signals in single cells (Fig. 8b). Activation of the other P2Y receptor subtypes (P2Y1, P2Y4 and P2Y6) evokes smaller Ca2+ signals (Fig. 1), consistent with their expression in only a subset of the cells that express P2Y2 receptors (Fig. 4 and Table 2), and with the smaller amplitudes of the Ca2+ signals they evoke in single cells (Fig. 8). Expression of the four P2Y receptor subtypes is apparently randomly distributed between individual ASMC, with most cells expressing several functional P2Y receptor subtypes (Fig. 4c). This suggests that the four P2Y subtypes, each evoking Ca2+ signals in response to inter-related nucleotides, are unlikely simply to provide redundant means of achieving similar responses in different cells.
Despite the diversity of Ca2+ signals, each of the four P2Y receptor subtypes uses the same signalling machinery to increase [Ca2+] i . Each activates PLC (Fig. 1f) and thereby release of Ca2+ from intracellular stores via IP3R, without involvement of ryanodine or NAADP receptors (Fig. 5). Others have also concluded that IP3R are the predominant means of Ca2+ release evoked by growth factors in proliferating VSMC [1, 3].
The mechanisms underlying Ca2+ entry in cultured ASMC are more contentious. Rapid and substantial desensitisation of P2Y1 receptors prevents them from evoking sustained Ca2+ signals, but P2Y2, P2Y4 and P2Y6 receptors do stimulate Ca2+ entry (Figs. 1 and 2 and Table 1) [10]. Depletion of intracellular Ca2+ stores using thapsigargin activates SOCE in cultured rat ASMC (Fig. 6d), and others have shown that SOCE is attenuated by knockdown of Orai1 and STIM1 in ASMC [34, 40]. STIM1 is the sensor of luminal Ca2+ within the endoplasmic reticulum and Orai1 is a pore-forming subunit of a SOCE pathway. Whether, under physiological conditions, STIM1 activates Orai directly [41] or via an intervening biochemical sequence [42] is not entirely resolved. TRPC channels, which may also be activated by STIM1 and associate with Orai proteins, may also contribute to SOCE [43, 44], although this suggestion is disputed [36]. Several studies have suggested a role for TRPC1 in mediating SOCE in VSMC [45], but this is also contentious. Others suggest that in cultured ASMC, knockdown of Orai1 attenuates SOCE current, while loss of TRPC1, TRPC4 or TRPC6 does not [34]. Furthermore, Ca2+ entry evoked by PDGF in ASMC is mediated by STIM1 and Orai1, and resembles SOCE in its inhibition by low concentrations of Gd3+ and 2-APB [39].
An alternative role for TRPC proteins in contributing to Ca2+ entry suggests that ATP-evoked Ca2+ entry is mediated by TRPC6 and the NCX working in reverse mode [31, 32]. Our results suggest that NCX does not contribute to the Ca2+ entry evoked by P2Y receptors (Fig. 6b, c) and that SOCE alone is probably sufficient to account for the Ca2+ entry evoked by P2Y receptors (Figs. 6 and 7 and Tables 3 and 4), although we cannot entirely exclude a minor role for stimulation of an additional Ca2+ entry pathway by P2Y4 and P2Y6 receptors.
Despite the shared signalling pathways, the four P2Y receptors evoke Ca2+ signals with different characteristics (Fig. 1) that appear to be substantially due to differing patterns of homologous desensitisation (Fig. 2). Homologous desensitisation of P2Y1 receptors, which is mediated by protein kinase C and by G protein receptor kinases in other cells [46, 47], is most pronounced (Fig. 2) and causes the Ca2+ signals in ASMC to terminate before there is detectable Ca2+ entry (Figs. 1a and 8a). There is no evidence for homologous desensitisation of P2Y4 receptors (Fig. 2), consistent with their ability to evoke sustained responses (Figs. 1a and 8c) and considerable Ca2+ entry (Fig. 1d). P2Y2 and P2Y6 receptors show intermediate levels of homologous desensitisation, with the latter recovering most quickly (Fig. 2). This is consistent with the ability of both receptor subtypes to stimulate sustained Ca2+ entry (Fig. 1). It is tempting to speculate that the consistent triggering of Ca2+ oscillations by P2Y6 receptors (Fig. 8d) may be driven by their substantial, but rapidly reversed, homologous desensitisation (Fig. 2c). Within a physiological setting, where endogenous nucleotides are likely to cause parallel activation of several P2Y receptor subtypes in the same cell (Fig. 4c), the temporal pattern of Ca2+ signals is likely to be further shaped by the ability of P2Y2 receptors to cause heterologous desensitisation of each of the other subtypes (Table 1).
We conclude that four P2Y receptor subtypes (P2Y1, P2Y2, P2Y4 and P2Y6) evoke Ca2+ signals in ASMC via signalling pathways that require activation of PLC, release of Ca2+ from IP3-sensitive Ca2+ stores and consequent activation of SOCE. Despite the shared signalling machinery, the patterns of Ca2+ signalling evoked by different P2Y receptors differ profoundly. We suggest that the differences are due largely to different patterns of homologous desensitisation.
References
House SJ, Potier M, Bisaillon J, Singer HA, Trebak M (2008) The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456:769–785
Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801
Vallot O, Combettes L, Jourdon P, Inamo J, Marty I, Claret M, Lompre AM (2000) Intracellular Ca2+ handling in vascular smooth muscle cells is affected by proliferation. Pflugers Arch 20:1225–1235
Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA (2008) Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol 295:C779–C790
Thyberg J (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169:183–265
Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Artero Thromb Vasc Biol 23:1510–1520
Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341
Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Artero Thromb Vasc Biol 22:364–373
Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438–1445
Govindan S, Taylor EJA, Taylor CW (2010) Ca2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells. Br J Pharmacol 160:1953–1962
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450
Erlinge D, Hou M, Webb TE, Barnard EA, Moller S (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248:864–870
Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311:1038–1043
Jacobson KA, Costanzi S, Ivanov AA, Tchilibon S, Besada P, Gao ZG, Maddileti S, Harden TK (2006) Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors. Biochem Pharmacol 71:540–549
Fricks IP, Maddileti S, Carter RL, Lazarowski ER, Nicholas RA, Jacobson KA, Harden TK (2008) UDP is a competitive antagonist at the human P2Y14 receptor. J Pharmacol Exp Ther 325:588–594
Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276:11939–11948
Robaye B, Boeynaems JM, Communi D (1997) Slow desensitization of the human P2Y6 receptor. Eur J Pharmacol 329:231–236
Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA (2000) ATP, an agonist at the rat P2Y4 receptor, is an antagonist at the human P2Y4 receptor. Mol Pharmacol 57:926–931
Brass D, Grably MR, Bronstein-Sitton N, Gohar O, Meir A (2011) Using antibodies against P2Y and P2X receptors in purinergic signaling research. Purinergic Signal 8:61–79
Lesh RE, Nixon GF, Fleischer S, Airey JA, Somlyo AP, Somlyo AV (1998) Localization of ryanodine receptors in smooth muscle. Circl Res 82:175–185
Thai TL, Churchill GC, Arendshorst WJ (2009) NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am J Physiol 297:F510–F516
Taylor CW, Broad LM (1998) Pharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. Trends Pharmacol Sci 19:370–375
Santonastasi M, Wehrens XH (2007) Ryanodine receptors as pharmacological targets for heart disease. Acta Pharm Sinica 28:937–944
Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, Rosen D, Thomas JM, Izumi M, Ganesan A, Galione A, Churchill GC (2009) Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol 5:220–226
Brailoiu E, Rahman T, Churamani D, Prole DL, Brailoiu GC, Taylor CW, Patel S (2010) An NAADP-gated two-pore channel targeted to the plasma membrane uncouples triggering from amplifying Ca2+ signals. J Biol Chem 285:38611–38616
Taylor CW, Tovey SC (2010) IP3 receptors: toward understanding their activation. Cold Spring Harb Persp Biol 2:a004010
Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL (2003) 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34:97–108
Missiaen L, Callewaert G, De Smedt H, Parys JB (2001) 2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores of permeabilized A7r5 cells. Cell Calcium 29:111–116
Goto J, Suzuki AZ, Ozaki S, Matsumoto N, Nakamura T, Ebisui E, Fleig A, Penner R, Mikoshiba K (2010) Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca2+ entry via STIM proteins. Cell Calcium 47:1–10
Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, Peppiatt CM (2002) 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J 16:1145–1150
Lemos VS, Poburko D, Liao CH, Cole WC, van Breemen C (2007) Na+ entry via TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352:130–134
Syyong HT, Poburko D, Fameli N, van Breemen C (2007) ATP promotes NCX-reversal in aortic smooth muscle cells by DAG-activated Na+ entry. Biochem Biophys Res Commun 357:1177–1182
Iwamoto T, Watano T, Shigekawa M (1996) A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271:22391–22397
Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA, Trebak M (2009) Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23:2425–2437
Broad LM, Cannon TR, Taylor CW (1999) A non-capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol 517:121–134
Putney JW (2009) Capacitative calcium entry: from concept to molecules. Immunol Rev 231:10–22
Prakriya M, Lewis RS (2001) Potentiation and inhibition of Ca2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors. J Physiol 536:3–19
Peinelt C, Lis A, Beck A, Fleig A, Penner R (2008) 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J Physiol 586:3061–3073
Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF, Barroso M, Singer HA, Jourd'heuil D, Trebak M (2010) Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol 298:C993–C1005
Baryshnikov SG, Pulina MV, Zulian A, Linde CI, Golovina VA (2009) Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. Am J Physiol 297:C1103–C1112
Lewis RS (2007) The molecular choreography of a store-operated calcium channel. Nature 446:284–287
Bolotina VM (2008) Orai, STIM1 and iPLA2β: a view from a different perspective. J Physiol 586:3035–3042
Zeng W, Yuan JP, Kim MS, Choi YJ, Huang GN, Worley PF, Muallem S (2008) STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol Cell 32:439–448
Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L (2007) Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 104:4682–4687
Albert AP, Saleh SN, Peppiatt-Wildman CM, Large WA (2007) Multiple activation mechanisms of store-operated TRPC channels in smooth muscle cells. J Physiol 583:25–36
Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105:3552–3560
Rodriguez-Rodriguez R, Yarova P, Winter P, Dora KA (2009) Desensitization of endothelial P2Y1 receptors by PKC-dependent mechanisms in pressurized rat small mesenteric arteries. Br J Pharmacol 158:1609–1620
Acknowledgements
This work was supported by the Medical Research Council [0700843] and the Wellcome Trust [085295]. We thank Emily Taylor for assistance with experiments and Mohamed Trebak (Albany Medical College, USA) for helpful advice.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 212 kb)
Rights and permissions
About this article
Cite this article
Govindan, S., Taylor, C.W. P2Y receptor subtypes evoke different Ca2+ signals in cultured aortic smooth muscle cells. Purinergic Signalling 8, 763–777 (2012). https://doi.org/10.1007/s11302-012-9323-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-012-9323-6